Balchem Reports Second Quarter 2026 Financial Results

Montvale, NJ, July 31, 2026 – Balchem today reported financial results for its 2026 fiscal second quarter ended June 30, 2026. For the quarter, the Company reported net sales of $284.0 million, net earnings of $44.6 million, adjusted EBITDA^(a) of $77.9 million, and free cash flow^(a) of $36.2 million.Ted Harris, Chairman, President and CEO of Balchem, said, “The second quarter was another very strong quarter for Balchem with healthy growth in all three of our reporting segments. On a consolidated basis, we delivered record quarterly net sales, net earnings, and adjusted EBITDA, as well as solid cash flows.”

Second Quarter 2026 Financial Highlights:

• Net sales were $284.0 million, an increase of 2% from the prior year quarter.
• GAAP net earnings were $44.6 million, an increase of 6% from the prior year quarter.
• Adjusted EBITDA was $77.9 million, an increase of 6% from the prior year quarter.
• GAAP earnings per share were $1.39 compared to $1.17 in the prior year quarter and adjusted earnings per share^(a) were $1.49 compared to $1.27 in the prior year quarter.
• Cash flows from operations were $46.7 million, with free cash flow^(a) of $36.2 million.
• Excellent sales and earnings from operations growth in all three of our reporting segments.

Recent Highlights:

• On July 24, 2026, we entered into an amendment to our existing credit agreement, that was due July 27, 2027, with lenders in the form of a senior secured revolving credit facility, now due July 24, 2031. This amendment increased the allowed borrowing from $550 million to $650 million, and expanded the company’s ability to fund growth, innovation, and acquisitions.
• Balchem repurchased $29 million of common stock during the second quarter and $114 million over the trailing twelve months, reflecting the Company’s balanced capital allocation strategy and commitment to long-term shareholder value creation.